McKesson Corp. Stock
Price
Target price
€625.80
€625.80
5.890%
34.8
5.890%
€672.11
19:34 / Tradegate
WKN: 893953 / Symbol: MCK / Name: McKesson / Stock / Food & Drug Retailing / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
McKesson Corp. Stock
McKesson Corp. dominated the market today, gaining €34.80 (5.890%).
With 19 Buy predictions and not the single Sell prediction the community is currently very high on McKesson Corp..
With a target price of 672 € there is a slightly positive potential of 7.38% for McKesson Corp. compared to the current price of 625.8 €.
Pros and Cons of McKesson Corp. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of McKesson Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
McKesson Corp. | 5.890% | -1.071% | 0.510% | 29.862% | 7.455% | 67.612% | 368.824% |
CVS Health Corp. | 1.870% | 1.970% | 4.685% | 23.602% | 49.782% | -37.236% | 28.258% |
Cardinal Health Inc. | 3.800% | -2.153% | -1.108% | 24.750% | 10.522% | 82.375% | 210.907% |
AmerisourceBergen Corp. | 2.040% | -1.211% | -1.884% | 19.677% | 13.045% | 73.347% | 198.537% |
Comments
McKesson Corporation (NYSE: MCK) had its "buy" rating re-affirmed by analysts at Cowen Inc.
Show more
Ratings data for MCK provided by MarketBeat
McKesson Corporation (NYSE: MCK) had its price target raised by analysts at Morgan Stanley from $770.00 to $810.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat
McKesson Corporation (NYSE: MCK) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for MCK provided by MarketBeat
News

Why McKesson Stock Bumped Modestly Higher Today
Storied healthcare supplies company McKesson (NYSE: MCK) was a slight outperformer on the stock exchange Friday, as investors considered its results for its fourth quarter of fiscal 2025. They

3 Safe Dividend Stocks as Investors Seek to Reset Diversification
Over the last three years, diversification has fallen out of fashion. When investors can make 20% or higher returns in technology stocks and even more from the Magnificent 7, the idea of investing